Charles J. Homcy
Director · BridgeBio Pharma, Inc.
- 2025
- Jun 24, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Charles J. Homcy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- Jennifer E. Cook - $21.92M in BBIO purchases and sales in the last 12 months
- Frank McCormick - $13.31M in BBIO purchases and sales in the last 12 months
- Harold Bernstein - $7.44M in MAZE purchases and sales in the last 12 months
- Andrew Lo - $6.32M in BBIO purchases and sales in the last 12 months
- Jason V. Coloma - $6.19M in MAZE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Charles J. Homcy?
Charles J. Homcy is a corporate insider, tracked as Director of BridgeBio Pharma, Inc. (BBIO). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Charles J. Homcy last file a Form 4?
The most recent primary Form 4 on record is dated 24 June 2026, one of 10 filings going back to 2025.
Has Charles J. Homcy been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($13.91M) across all tracked filings.
